Literature DB >> 3612129

Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain.

F A Welsh, T Sakamoto, A E McKee, R E Sims.   

Abstract

Brain levels of NADH and NAD+ were measured in three models of cerebral ischemia to determine whether degradation of the pyridine nucleotides is enhanced in models that generate high concentrations of lactic acid. Complete ischemia (decapitation), in which lactate increased to 14 mmol/kg, caused a gradual decrease in the NAD pool to 50% of control by 2 h. During focal ischemia (occlusion of the middle cerebral artery), the decrease in the NAD pool was less pronounced (82% of control at 2 h) despite the accentuated accumulation of lactate to 33 mmol/kg. In a third model (unilateral hypoxia-ischemia), pretreatment of animals with glucose augmented the ischemic elevation of lactate from 30 mmol/kg to 40 mmol/kg and greatly impaired restoration of energy metabolites during recirculation. However, glucose pretreatment had no effect on the size of the NAD pool during ischemia or early recovery. These results, therefore, demonstrate that the pyridine nucleotide pool is not rapidly degraded during ischemic insults that accumulate high concentrations of lactic acid. The stability of the NAD pool may have been enhanced by the limited increase in brain levels of NADH that occurred in these models of incomplete ischemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3612129     DOI: 10.1111/j.1471-4159.1987.tb00971.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

1.  Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes.

Authors:  Vivian Tseveleki; Renee Rubio; Sotiris-Spyros Vamvakas; Joseph White; Era Taoufik; Edwige Petit; John Quackenbush; Lesley Probert
Journal:  Genomics       Date:  2010-05-07       Impact factor: 5.736

2.  Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.

Authors:  H J Marti; M Bernaudin; A Bellail; H Schoch; M Euler; E Petit; W Risau
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Possible therapeutic effect of naftidrofuryl oxalate on brain energy metabolism after microsphere-induced cerebral embolism.

Authors:  K Miyake; K Tanonaka; R Minematsu; K Inoue; S Takeo
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

4.  Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.

Authors:  P J Birch; H Rogers; A G Hayes; N J Hayward; M B Tyers; D I Scopes; A Naylor; D B Judd
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

5.  Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation.

Authors:  Dean A Le; Yongqin Wu; Zhihong Huang; Kohji Matsushita; Nikolaus Plesnila; Jean C Augustinack; Bradley T Hyman; Junying Yuan; Keisuke Kuida; Richard A Flavell; Michael A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

6.  Redox-Dependent Loss of Flavin by Mitochondrial Complex I in Brain Ischemia/Reperfusion Injury.

Authors:  Anna Stepanova; Sergey Sosunov; Zoya Niatsetskaya; Csaba Konrad; Anatoly A Starkov; Giovanni Manfredi; Ilka Wittig; Vadim Ten; Alexander Galkin
Journal:  Antioxid Redox Signal       Date:  2019-07-01       Impact factor: 8.401

7.  In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure.

Authors:  Fabien Chauveau; Samir Moucharrafie; Marlène Wiart; Jean-Christophe Brisset; Yves Berthezène; Norbert Nighoghossian; Tae-Hee Cho
Journal:  Exp Transl Stroke Med       Date:  2010-02-04

8.  Angiopoietin-2 is vasoprotective in the acute phase of cerebral ischemia.

Authors:  Léna Marteau; Samuel Valable; Didier Divoux; Simon A Roussel; Omar Touzani; Eric T MacKenzie; Myriam Bernaudin; Edwige Petit
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-05       Impact factor: 6.200

9.  Complement: a novel factor in basal and ischemia-induced neurogenesis.

Authors:  Yalda Rahpeymai; Max Albert Hietala; Ulrika Wilhelmsson; Andrew Fotheringham; Ioan Davies; Ann-Katrin Nilsson; Jörg Zwirner; Rick A Wetsel; Craig Gerard; Milos Pekny; Marcela Pekna
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

10.  TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury.

Authors:  Era Taoufik; Edwige Petit; Didier Divoux; Vivian Tseveleki; Manuela Mengozzi; Michael L Roberts; Samuel Valable; Pietro Ghezzi; John Quackenbush; Michael Brines; Anthony Cerami; Lesley Probert
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.